Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus.
(Q41103590)
scientific article published on June 1997
scientific article published on June 1997
Language:
other details
| description | scientific article published on June 1997 |
External Links
| (P356) |
10.1016/S0014-5793(97)00616-9
|
| (P698) |
9237655
|